Stocktoria
PharmaCyte Biotech, Inc. PMCB
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2003-09-11
PharmaCyte Biotech, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 519,747 | $345,840 | 4.84% |
| RENAISSANCE TECHNOLOGIES LLC | 56,500 | $37,595 | 0.53% |
| BlackRock Finance, Inc. | 13,346 | $26,158 | 0.12% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.